Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
IgY Nutrition produces and markets hyperimmune egg-based supplements, notably "IgY Max", which use immunized egg powder to deliver targeted immune support for gut and digestive health. Their products are commercially available as dietary supplements aimed at improving bacterial diversity in the gut, reducing non-beneficial bacteria, promoting beneficial flora growth, and supporting immune function. Clinical studies referenced by the company suggest benefits for gastrointestinal integrity and overall quality of life related to gut health[2][3].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on IgY Nutrition.